Licopid® (or Lycopid) is the immunomodulator containing a complete synthetic analog of natural GMDP or glucosaminyl muramyl dipeptide.
Once in the body, Lycopid® mimics the natural process of detecting fragments of peptidoglycan bacteria. Thus, the effect of the drug is as close as possible to the process of natural immunoregulation.
GMDP also demonstrates other useful properties obtained in experimental studies: antitumor and antimetastatic effects and adjuvant properties (increased antibody production during immunization, which is especially important when introducing killed or "weakened" antigens). These are the new promising areas of scientific research for the future.
Can assist in treating:
Dosage and Administration
Lycopid® is administered orally or sublingually in the fasting state, 30 minutes before meals.